Filing Details
- Accession Number:
- 0001209191-19-058699
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-03 16:20:46
- Reporting Period:
- 2019-11-29
- Accepted Time:
- 2019-12-03 16:20:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1615842 | P Barry Flannelly | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp & General Manager Us | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-11-29 | 600 | $73.21 | 17,579 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-11-29 | 600 | $95.00 | 16,979 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-12-02 | 6,582 | $73.21 | 23,561 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-12-02 | 6,582 | $95.00 | 16,979 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-11-29 | 600 | $0.00 | 600 | $73.21 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2019-12-02 | 6,582 | $0.00 | 6,582 | $73.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,346 | 2022-01-07 | No | 4 | M | Direct | |
13,764 | 2022-01-07 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Includes an aggregate of 13,951 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.
- Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years